Phase II Combination Steroid and Anti-VEGF for Persistent DME

Condition:   Diabetic Macular Edema
Interventions:   Drug: intravitreal ranibizumab 0.3 mg;   Drug: dexamethasone intravitreal implant;   Procedure: Sham injection
Sponsors:   Diabetic Retinopathy Clinical Research Network;   Diabetic Retinopathy Clinical Research Network;   Allergan;   Genentech
Not yet recruiting – verified September 2013

Leave a Reply

You can use these HTML tags

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

  

  

  

8 − 5 =